GlassScriptPhysician profile
Robert G Nelson
NPI 1255967824
$9,443.95
in general payments reported to CMS, 2019-2025
44 companies · $3,064 in 2025
The $3,064 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $1,422 · 2023: $1,725 · 2024: $3,129 · 2025: $3,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,642 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,641.53 |
| Education | $277.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,411.27 | 2022-2023 | Intracept |
| Abbvie INC. | $1,213.55 | 2023-2025 | |
| Pfizer INC. | $670.50 | 2023-2025 | |
| Ucb, INC. | $508.31 | 2023-2025 | Briviact, Nayzilam, Zilbrysq |
| Lundbeck LLC | $456.54 | 2023-2025 | Vyepti |
| Sk Life Science, INC. | $428.26 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $399.11 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $367.25 | 2023-2025 | Ultomiris, Soliris |
| Lilly USA, LLC | $313.30 | 2023-2025 | Amyvid, Emgality, Reyvow |
| Biogen, INC. | $298.74 | 2023-2025 | Leqembi, Tysabri, Skyclarys |
| Emd Serono, INC. | $273.83 | 2024-2025 | |
| Tg Therapeutics, INC. | $271.32 | 2024-2025 | |
| Neurelis, INC. | $237.60 | 2024-2025 | Valtoco |
| Grifols USA, LLC | $216.89 | 2023-2025 | Gamunex-C |
| Si-Bone, INC. | $214.69 | 2021-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $206.69 | 2023-2025 | Uplizna, Aimovig |
| Genentech USA, INC. | $166.01 | 2023-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Neurocrine Biosciences, INC. | $135.52 | 2023-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $130.82 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Otsuka America Pharmaceutical, INC. | $129.39 | 2023-2024 | Rexulti, Nuedexta |
| Astrazeneca Pharmaceuticals LP | $107.54 | 2023-2025 | Wainua |
| Axsome Therapeutics, INC. | $98.94 | 2025 | Symbravo |
| Banner Life Sciences, LLC | $98.08 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $94.98 | 2023-2025 | Acthar |
| Sumitomo Pharma America, INC. | $94.21 | 2023-2024 | Aptiom |
| Eisai INC. | $92.78 | 2023-2024 | |
| Amneal Pharmaceuticals LLC | $91.18 | 2023-2025 | Rytary, Crexont |
| Scilex Pharmaceuticals INC. | $69.85 | 2023-2025 | Ztlido |
| Beta Bionics, INC. | $58.65 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Jazz Pharmaceuticals INC. | $57.81 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.43 | 2024 | Hyqvia |
| Azurity Pharmaceuticals, INC. | $53.61 | 2024-2025 | Horizant |
| Catalyst Pharmaceuticals, INC. | $52.60 | 2024 | |
| Mdd US Operations, LLC | $52.07 | 2024 | Gocovri |
| Boston Scientific Corporation | $46.58 | 2023 | Wavewriter Alpha Prime 16 |
| Corium, LLC | $45.43 | 2023 | Adlarity |
| Genzyme Corporation | $43.39 | 2025 | |
| Springworks Therapeutics, INC. | $34.25 | 2025 | Gomekli |
| Medtronic, INC. | $32.44 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $31.40 | 2025 | Nuplazid |
| Stryker Corporation | $30.19 | 2023 | Capri Corpectomy Cage System |
| Teva Pharmaceuticals USA, INC. | $20.18 | 2024 | Ajovy |
| Inspire Medical Systems, INC. | $17.44 | 2024 | Inspire |
| Impel Pharmaceuticals INC. | $14.33 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.